While the 5-year survival rate for local and regional prostate cancer is nearly 100%, it decreases dramatically for advanced tumours. Accessibility to health care is an important factor for cancer prognosis. The U.S. Military Health System (MHS) provides universal health care to its beneficiaries...
British Journal of Cancer volume 128, pages 63–70 (2023)Cite this article 297 Accesses Metrics details Abstract Background Socioeconomic deprivation has been associated with lower breast cancer (BC) survival, but the influence of stage at diagnosis on this association merits further study. Our ...
3-5 About Advanced Non-Small Cell Lung Cancer and the KRAS G12C MutationLung cancer is the leading cause of cancer-related deaths worldwide, and it accounts for more deaths worldwide than colon cancer, breast cancer and prostate cancer combined.6 KRAS G12C is the most...
3,4 The Oncotype DX Breast RS test is a multigene assay that assesses the expression of 16 genes associated with breast cancer, including those encoding ER, PR, HER2, and Ki-67, in addition to 5 reference genes, to generate an RS ranging from 0 to 100 that indicates the risk of cancer...
2023;13(10). Zhang J, Zhao X, Zhao Y, Zhang J, Zhang Z, Wang J, et al. Value of pre-therapy (18)F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2020;47(5):1137–46. Article CAS PubMed ...
1“[Osimertinib] continues to serve patients as a backbone therapy in EGFR-mutated lung cancer, extending PFS in the LAURA trial by more than 3 years and reinforcing the importance of testing for EGFR mutations at the time of diagnosis." The randomized, double-blind LAURA trial enroll...
2.2.3Solid tumor XTs Although zebrafish lack mammary glands, prostate tissue, and lungs, studies have proven zebrafish to be a good model for studying human breast and prostate cancer by using XT. One study looked at metastasis and dissemination of breast, colorectal, and prostate cancer cell li...
Currently, little is known about the phenotypes of circulating tumor cells (CTCs), particularly epithelial and mesenchymal phenotypes, and their impact on the prognosis of colorectal cancer (CRC) patients. This study aims to investigate the CTC phenotypes and their prognostic implications in stage III...
While, endometrial, breast, cervical and ovarian cancer samples were found to have 5971, 5982, 6300 and 6336 respectively. Full size image Figure 3 Data processing pipeline. The data preprocessing pipeline used to render the data amenable to AI modeling is depicted here (details are given in ...
Paz-Ares L, Champiat S, Lai WV, et al. Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study.J Clin Oncol. 2023;41:2893-2903....